January 2010 Briefing - UrologyLast Updated: February 01, 2010.
Here are what the editors at HealthDay consider to be the most important developments in Urology for January 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Immunotherapy for Metastatic Prostate Cancer Explored
FRIDAY, Jan. 29 (HealthDay News) -- Treatment with a prostate-specific antigen (PSA)-targeted poxviral vaccine substantially improves overall survival among metastatic prostate cancer patients, according to the results of a phase II study published online Jan. 25 in the Journal of Clinical Oncology.
Lifestyle Affects Incontinence Risk After Prostatectomy
THURSDAY, Jan. 28 (HealthDay News) -- In men who undergo radical prostatectomy, obesity and physical inactivity are associated with an increased prevalence of urinary incontinence, according to a study in the February issue of The Journal of Urology.
Obesity Shown to Impact Incontinence Severity
THURSDAY, Jan. 28 (HealthDay News) -- Obese women with urinary incontinence have more severe symptoms than their overweight or normal weight counterparts, according to trial results published in the February issue of The Journal of Urology.
Increased Medicare Copayments Affect Care Usage
WEDNESDAY, Jan. 27 (HealthDay News) -- In elderly patients, increasing copayments for ambulatory care may result in adverse health consequences and increased health care spending, according to a study in the Jan. 28 issue of the New England Journal of Medicine.
Prostate Cancer Treatment May Differ by Provider Type
WEDNESDAY, Jan. 27 (HealthDay News) -- Prostate cancer treatment for low-income men differs significantly between private providers and county hospitals, according to a study published online Jan. 25 in Cancer.
Review of Enuresis in Over-5s Conducted
WEDNESDAY, Jan. 27 (HealthDay News) -- Nighttime bedwetting in children over the age of 5 years is a condition that requires proper evaluation and treatment, according to a report in the February issue of The Journal of Urology.
Later Toilet Training Linked to Childhood Urge Incontinence
FRIDAY, Jan. 22 (HealthDay News) -- Beginning toilet training in toddlers after the age of 32 months may increase the likelihood of later urge incontinence, according to research published in the December issue of the Journal of Pediatric Urology.
Nurses Often Deeply Affected by Workplace Errors
THURSDAY, Jan. 21 (HealthDay News) -- Nurses are deeply affected by errors they make in the intraoperative environment and need more guidance on what constitutes an error in order to encourage more open reporting, according to a study in the Jan. 10 issue of the AORN Journal.
Tylenol Recall in Effect Includes Several Other Drugs
WEDNESDAY, Jan. 20 (HealthDay News) -- McNeil Consumer Healthcare has recently expanded its voluntary recall of some over-the-counter drugs to include about 500 lots of products, according to officials from the Office of Compliance in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration.
Erectile Dysfunction May Not Aid Heart Disease Prediction
TUESDAY, Jan. 19 (HealthDay News) -- Although erectile dysfunction (ED) is associated with risk of cardiovascular disease (CVD), it does not appear to improve upon the prediction provided by the Framingham risk score, according to research published in the Jan. 26 issue of the Journal of the American College of Cardiology.
Biomedical Research Funding Shows Decline in 2008
TUESDAY, Jan. 12 (HealthDay News) -- After increasing since 1994, annual funding for biomedical research topped out at $90.2 billion in 2007 and began to decline in 2008, according to a study in the Jan. 13 issue of the Journal of the American Medical Association.
Clinical Benefits of Circumcision Remain Unclear
TUESDAY, Jan. 12 (HealthDay News) -- Although strong evidence shows that circumcision can prevent HIV infection in sub-Saharan African men, it's unclear if the procedure is associated with an overall reduced risk of sexually transmitted infections, urinary tract infections or penile cancer, according to a study in the January/February issue of the Annals of Family Medicine.
Imetelstat Shows Potential for Prostate, Brain Cancer
FRIDAY, Jan. 8 (HealthDay News) -- The telomerase inhibitor imetelstat may be useful in treating glioblastoma and prostate cancer, according to research published online Jan. 4 in Clinical Cancer Research and online Nov. 11 in the International Journal of Cancer.
Erectile, Depression Issues Common in Heart Disease
WEDNESDAY, Jan. 6 (HealthDay News) -- Erectile dysfunction (ED) and symptoms of depression are both common in men with coronary artery disease (CAD), according to research published in the January issue of Urology.
Tamsulosin Enhances Passage of Stones in the Lower Ureter
WEDNESDAY, Jan. 6 (HealthDay News) -- The alpha-1 adrenergic receptor antagonist tamsulosin is nearly three times more effective than placebo at enhancing the spontaneous passage of lower ureteral stones, according to a study reported in the January issue of Urology.
Bladder Cancer Deemed Rare in Men With Microhematuria
TUESDAY, Jan. 5 (HealthDay News) -- The eventual development of bladder cancer in men who test positive for asymptomatic microhematuria (MH) is less than 1 percent, calling into question professional guidelines recommending intensive follow-up evaluation for bladder cancer in such patients, according to a study in the January issue of Urology.
|Previous: January 2010 Briefing - Surgery||Next: January 2010 Briefing - Internal Medicine|
Reader comments on this article are listed below. Review our comments policy.